Biocytogen
Advanced biotechnology company.
Launch date
Employees
Market cap
-
Enterprise valuation
$357m (Public information from Sep 2022)
Wakefield Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- |
| N/A | - |
* | N/A | N/A | Series A |
N/A | Series B | ||
JPY410m | Series C | ||
$77.1m | Series D | ||
$142m | Series D | ||
$10.0m Valuation: $710m | Late VC | ||
* | N/A | $60.0m Valuation: $357m | IPO |
Total Funding | $232m |
Related Content
Recent News about Biocytogen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.